Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07576205
Effects of Paula Exercises and Tibial Nerve Stimulation in Stress Urinary IncontinenceRiphah International UniversityRecruitingNot Applicable
NCT07576205Recruiting
Not Applicable
Effects of Paula Exercises and Tibial Nerve Stimulation in Stress Urinary Incont...Riphah International Univ...
NCT07574840
Allogeneic Dental Pulp Stem Cells for the Treatment of PeriodontitisThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574840Not Yet Recruiting
Not Applicable
Allogeneic Dental Pulp Stem Cells for the Treatment of PeriodontitisThe First Affiliated Hosp...
NCT07576595
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansLouisiana State University Health Sciences Center in New OrleansRecruitingNot Applicable
NCT07576595Recruiting
Not Applicable
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Amo...Louisiana State Universit...
NCT07574931
Outcome of Ablation of Tachyarrhythmias in Patients With Congenital Heart DiseasesFayoum UniversityCompleted
NCT07574931Completed
—
Outcome of Ablation of Tachyarrhythmias in Patients With Congenital Heart Diseas...Fayoum University
NCT07574671
Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast CancerNational Cancer Institute (NCI)RecruitingNot Applicable
NCT07574671Recruiting
Not Applicable
Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cance...National Cancer Institute...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07576426
Effects of Motor Control Retraining and Scapular Stabilization Exercises in Females With Scapular Dyskinesia.Riphah International UniversityRecruitingNot Applicable
NCT07576426Recruiting
Not Applicable
Effects of Motor Control Retraining and Scapular Stabilization Exercises in Fema...Riphah International Univ...
NCT07574606
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle FlapFuture University in EgyptRecruitingNot Applicable
NCT07574606Recruiting
Not Applicable
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla...Future University in Egyp...
NCT07576127
Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in Patients With Adhesive CapsulitisRiphah International UniversityRecruitingNot Applicable
NCT07576127Recruiting
Not Applicable
Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in P...Riphah International Univ...
NCT07576881
Impact of Standardization on Outcomes Following Cervical RipeningIndiana UniversityNot Yet RecruitingPhase 2
NCT07576881Not Yet Recruiting
Phase 2
Impact of Standardization on Outcomes Following Cervical RipeningIndiana University
NCT07574684
Clinical Effects of Alpha-Lipoic Acid in Advanced NSCLCAin Shams UniversityNot Yet RecruitingPhase 2
NCT07574684Not Yet Recruiting
Phase 2
Clinical Effects of Alpha-Lipoic Acid in Advanced NSCLCAin Shams University
NCT07576985
Evaluating the Efficacy of Intravenous Acetaminophen (IV Tylenol) in Reducing Pain and Agitation in Pediatric Patients Undergoing Elective Tonsillectomy and/or AdenoidectomyMetroHealth Medical CenterEnrolling By Invitation
NCT07576985Enrolling By Invitation
—
Evaluating the Efficacy of Intravenous Acetaminophen (IV Tylenol) in Reducing Pa...MetroHealth Medical Cente...
NCT07576374
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesCentre Hospitalier Universitaire de la GuadeloupeNot Yet Recruiting
NCT07576374Not Yet Recruiting
—
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Ind...Centre Hospitalier Univer...
NCT07575490
Impact of Post-Cesarean Abdomino-Pelvic Training on Diastasis Recti and Sexual FunctionHarran UniversityNot Yet RecruitingNot Applicable
NCT07575490Not Yet Recruiting
Not Applicable
Impact of Post-Cesarean Abdomino-Pelvic Training on Diastasis Recti and Sexual F...Harran University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07576998
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE TrialMicrovention-Terumo, Inc.Not Yet RecruitingNot Applicable
NCT07576998Not Yet Recruiting
Not Applicable
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic S...Microvention-Terumo, Inc.
NCT07576387
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare HamiltonNot Yet RecruitingNot Applicable
NCT07576387Not Yet Recruiting
Not Applicable
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare H...
NCT07576322
Short-Term Safety and Performance of Two Wound Dressings EvaluationCHUV, Lausanne University Hospitals, SwitzerlandNot Yet RecruitingNot Applicable
NCT07576322Not Yet Recruiting
Not Applicable
Short-Term Safety and Performance of Two Wound Dressings EvaluationCHUV, Lausanne University...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed1 (5%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable12 (60%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 11 (5%)